Loxo Oncology Inc. | Mutual Funds
Mutual Funds that own Loxo Oncology Inc.
Fidelity Select Biotechnology Portfolio
846,934
2.78%
-228,900
1.56%
07/31/2018
T Rowe Price Health Sciences Fund
678,120
2.23%
75,500
0.9%
06/30/2018
Vanguard Small Cap Index Fund
643,491
2.11%
8,691
0.11%
07/31/2018
Vanguard Total Stock Market Index Fund
643,469
2.11%
736
0.01%
07/31/2018
T Rowe Price New Horizons Fund
626,133
2.06%
73,500
0.43%
06/30/2018
iShares Russell 2000 ETF
557,784
1.83%
-297
0.19%
09/06/2018
Oppenheimer Global Fund
553,760
1.82%
0
0.8%
03/31/2018
Polar Capital Funds Plc - Healthcare Opportunities Fund
469,971
1.54%
20,000
4.54%
07/31/2018
SPDR S&P Biotech ETF
409,996
1.35%
1,056
1.18%
09/06/2018
Vanguard Small Cap Value Index Fund
403,745
1.33%
3,807
0.21%
07/31/2018
| Address |
281 Tresser Boulevard
Stamford Connecticut 06901
United States
|
|
Employees
|
- |
| Website |
http://www.loxooncology.com |
| Updated |
09/14/2018 |
| Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. |
